Company Name, Ticker, Competitors, else..

Opiant Pharmaceuticals Inc (NASDAQ: OPNT)

Sector • Healthcare Industry • Major Pharmaceutical Preparations

Industry • Major Pharmaceutical Preparations

Sector • Healthcare

Opiant Pharmaceuticals Inc 's

Name: Opiant Pharmaceuticals Inc Comparisons to its Competitors and Market Share - CSIMarket
Creator: CSIMarket.com
License: https://csimarket.com/help/terms-of-use/

Competitiveness

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

OPNT Sales vs. its Competitors Q3 2022

Comparing the current results to its competitors, Opiant Pharmaceuticals Inc reported Revenue decrease in the 3 quarter 2022 year on year by -98.94 %, faster than the overall decrease of Opiant Pharmaceuticals Inc 's competitors by -95.24 %, recorded in the same quarter.

• List of OPNT Competitors

Select the Relationship:

Competition ▼

Select the Category:

Comparison ▼

Competition ▼

Basic Report▼

Revenue Growth Comparisons

Net Income Comparison

Opiant Pharmaceuticals Inc , faster than the decline experienced by the competitors recorded a net loss, as well as most of its competitors.

<< OPNT Stock Performance Comparisons

<< See the full list of OPNT competitors

Overall company Market Share Q3 2022

Overall company, revenue fell by -98.94 % and company lost market share, to approximately 21.96 %. << More on OPNT Market Share.

*Market share is calculated based on total revenue.

OPNT's Stock Performance relative to its Competitors

Publicly Traded Peers of Opiant Pharmaceuticals Inc

Achieve Life Sciences Inc
Share Performance

+61.97%

This Year

Achieve Life Sciences Inc

Profile

Achieve Life Sciences Inc's business model focuses on the development and commercialization of innovative therapies to help individuals quit smoking and combat nicotine addiction.

More about Achieve Life Sciences Inc 's Market Share

Market Cap.	Revenues TTM	Net Income TTM
$ 429.725 mill.	$ - mill.	$ -51.989 mill.

Anebulo Pharmaceuticals Inc
Share Performance

-38.46%

This Quarter

Anebulo Pharmaceuticals Inc

Profile

Anebulo Pharmaceuticals Inc operates on a business model focused on developing and commercializing innovative therapeutic solutions for respiratory diseases. They aim to identify and target unmet medical needs through research and development of novel drug formulations and delivery systems. By partnering with stakeholders and leveraging their expertise, Anebulo Pharmaceuticals Inc aims to provide effective treatments and improve the lives of patients with respiratory conditions.

More about Anebulo Pharmaceuticals Inc 's Market Share

Market Cap.	Revenues TTM	Net Income TTM
$ 13.147 mill.	$ - mill.	$ -7.979 mill.

Nutriband Inc
Share Performance

-3.61%

This Year

Nutriband Inc

Profile

Nutriband Inc operates through a business model focused on developing and commercializing innovative transdermal topicals and supplement products, utilizing their patented Nutrient Delivery System to enhance the absorption and effectiveness of nutraceutical and pharmaceutical ingredients.

More about Nutriband Inc 's Market Share

Market Cap.	Revenues TTM	Net Income TTM
$ 51.907 mill.	$ 1.803 mill.	$ -8.083 mill.

Sources: Opiant Pharmaceuticals Inc’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on: Saturday, August 29, 2026 7:24 AM
Focus of this report: publicly traded companies.
For your research, we’ve provided 10 tables on Opiant Pharmaceuticals Inc versus competitors, including market share analysis.
You can find them in the navigation menu under Competition.
To download the tables, please subscribe.

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.